New Evidence With BTK Inhibitor Therapy in CLL and MCL From the SOHO 2022 Annual Meeting

From Decera Clinical Education Oncology Podcast Decera Clinical Education

Listen to expert perspectives on select studies from the SOHO 2022 Annual Meeting covering BTK inhibition in chronic lymphocytic leukemia and mantle cell lymphoma and the potential implications for clinical practice.

Community discussion

Join the conversation

New Evidence With BTK Inhibitor Therapy in CLL and MCL From the SOHO 2022 Annual Meeting

You May Also Like

Das Kalenderblatt

Dare to Dream with Debbi Dachinger

SHIR HADASH

Supreme Being

FluentFiction - Estonian

Fluent Fiction - Norwegian

Fluent Fiction - Portuguese (Portugal) 🇵🇹

Fluent Fiction - Portuguese (Brazil) 🇧🇷

Fluent Fiction - Mandarin Chinese

FluentFiction - Romanian